Clinical trial · Interventional
Testing of the Cancer Thriving and Surviving Breast Cancer Program
Co-creating and Testing the Reach and Effectiveness of an Integrated Peer-to-peer Self-management Program for Breast Cancer Survivors: a Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The adjusted Cancer Thriving and Surviving Program (CTS) for women with breast cancer living in Switzerland (CTS-BC-CH) is a course of 7 weekly sessions of 2.5 - 3 hours led by trained peer-leaders (women with breast cancer experience). This pilot study aims to explore the reach of the CTS-BC-CH program (integrated into the clinical pathway) and to investigate its preliminary effectiveness with regard to Swiss breast cancer patients' self-efficacy and self-management.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasm | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Cancer Survivorship | — | UNRESOLVED | — |
| Early-Stage Breast Cancer | Early Stage Breast Carcinoma | ALIAS | 0.90 |
| Intervention | — | UNRESOLVED | — |
| Self-Management | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CTS-BC-CH | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Usual care
- description
- Usual follow-up care offered in the breast centers after primary treatment by breast care team (e. g. breast care nurses, gynaecologist, oncologist, psychologist).
- type
- EXPERIMENTAL
- label
- Usual care and CTS-BC-CH
- description
- CTS-BC-CH as 7 weekly group session à 2.5 - 3 hours.
- interventionNames
- Behavioral: CTS-BC-CH
Primary outcomes (2)
- measure
- Reach of intervention assessed by ratio of eligible patients vs. participating patients
- timeFrame
- 21 weeks after baseline
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion breast cancer patients * female gender * written informed consent * aged 18 years or older * diagnosed with an early stage breast cancer (stage 0, stage I, stage IIA, stage IIB, and stage IIIA breast cancers) * completed primary therapy (i. e. surgery, chemotherapy and/or radiation therapy) * at the beginning of follow-up care (including long-term endocrine therapy or targeted therapy) * free of recurrence * mentally able to participate, assessment of the psychological state performed by the responsible psychologist/psycho-oncologist in the breast center * treated in the participating breast center Inclusion course leaders * female gender * written informed consent * aged 18 years or older * diagnosed with an early stage breast cancer (stage 0, stage I, stage IIA, stage IIB, and stage IIIA breast cancers) * \> than 2 years post diagnosis * free of recurrence * mentally able to participate, assessment of the psychological state performed by the responsible psychologist/psycho-oncologist in the breast center * treated in the participating breast center * willing to participate in a course leaders training Exclusion breast cancer patients and course leaders * participation in another psycho-social intervention study * known illiteracy (reading and writing difficulties) * lack of language proficiency (German) Inclusion breast care nurses for CTS-BC-CH implementation * female gender * employed at breast care center \> 1 year * participation in 4-days CTS-BC-CH course leader training Inclusion breast care nurses for evaluating self-management support practices * nurses: graduated with a nurses diploma \> 1 year of breast cancer care experience
References
Publications (0)
Data not yet available